Login

Global Blood Therapeutics, Inc. SEC Filings

Filed On Filing
14 Feb 2023 SC 13G/A
09 Feb 2023 SC 13G/A
17 Oct 2022 15-12G
06 Oct 2022 Form 4: Perry Mark L, Director

Returned 37,865 shares to the issuer · Disposed of 3,600 Restricted Stock Units (Disposition to Issuer) · Disposed of 38,947 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Morrison Scott W, Director

Returned 6,637 shares to the issuer · Disposed of 3,600 Restricted Stock Units (Disposition to Issuer) · Disposed of 98,947 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Patrick Deval L, Director

Returned 9,037 shares to the issuer · Disposed of 3,600 Restricted Stock Units (Disposition to Issuer) · Disposed of 17,072 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Thompson Alexis A., Director

Returned 3,308 shares to the issuer · Disposed of 8,400 Restricted Stock Units (Disposition to Issuer) · Disposed of 18,212 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Yarno Wendy L, Director

Returned 11,437 shares to the issuer · Disposed of 3,600 Restricted Stock Units (Disposition to Issuer) · Disposed of 68,947 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Pizzo Philip A., Director

Returned 9,112 shares to the issuer · Disposed of 3,600 Restricted Stock Units (Disposition to Issuer) · Disposed of 68,947 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Svoronos Dawn, Director

Returned 5,376 shares to the issuer · Disposed of 3,600 Restricted Stock Units (Disposition to Issuer) · Disposed of 53,947 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Pierce Glenn, Director

Returned 26,437 shares to the issuer · Disposed of 3,600 Restricted Stock Units (Disposition to Issuer) · Disposed of 83,947 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Smith-Whitley Kim, See Remarks

Returned 5,980 shares to the issuer · Disposed of 102,434 Restricted Stock Units (Disposition to Issuer) · Disposed of 64,128 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Johnson David Lee, Chief Commercial Officer

Gave 22,000 shares as a gift · Returned 34,384 shares to the issuer · Disposed of 112,188 Restricted Stock Units (Disposition to Issuer) · 1 more

06 Oct 2022 Form 4: Choi Jung, See Remarks

Returned 251,672 shares to the issuer · Disposed of 110,313 Restricted Stock Units (Disposition to Issuer) · Disposed of 210,692 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Love Ted W, Director

Returned 922,618 shares to the issuer · Disposed of 399,622 Restricted Stock Units (Disposition to Issuer) · Disposed of 746,228 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Habibizad Nazila, See Remarks

Returned 39,680 shares to the issuer · Disposed of 62,549 Restricted Stock Units (Disposition to Issuer) · Disposed of 82,422 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Krehlik Carrie, Chief Human Resources Officer

Returned 6,716 shares to the issuer · Disposed of 108,494 Restricted Stock Units (Disposition to Issuer) · Disposed of 78,228 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Farrow Jeffrey S, Chief Financial Officer

Returned 26,739 shares to the issuer · Disposed of 110,313 Restricted Stock Units (Disposition to Issuer) · Disposed of 311,166 Stock Option (Right to Buy) (Disposition to Issuer)

06 Oct 2022 Form 4: Suvari Tricia Borga, Chief Legal Officer

Returned 43,077 shares to the issuer · Disposed of 110,313 Restricted Stock Units (Disposition to Issuer) · Disposed of 285,867 Stock Option (Right to Buy) (Disposition to Issuer)

05 Oct 2022 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support